Effects of Xuebijing injection on protein C and tumor necrosis factor-α mRNA in rats with sepsis

Chinese Critical Care Medicine

Volumn 19, Issue 8, 2007, Pages 488-491

  Li, Yin Ping ^a   Qiao, You Jie ^b   Wu, Zi Xia ^b   Qian, Fang Fang ^b   Yao, Yong Ming ^b   Yu, Yan ^b   Wu, Yao ^b  

^a Tianhe Hospital   (China)

^b NONE

Author keywords

Protein C; Sepsis; Tumor necrosis factor ; Xuebijing injection

Indexed keywords

CHINESE DRUG; MESSENGER RNA; PROTEIN C; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; XUEBIJING;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHINESE MEDICINE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG MECHANISM; GENE EXPRESSION; NONHUMAN; PROTEIN LOCALIZATION; RAT; SEPSIS; THROMBOCYTE COUNT; TISSUE DISTRIBUTION;

ANIMALS; DISEASE MODELS, ANIMAL; DRUGS, CHINESE HERBAL; MALE; PROTEIN C; RANDOM ALLOCATION; RATS; RATS, WISTAR; RNA, MESSENGER; SEPSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34548451733     PISSN: 10030603     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Chinese source.
2. Chinese source.
3. Tracey K J, Fong Y, Hesse D G, et al. Anti-cachectin/TNF monoclonal antibodies septic shock during lethal bacteraemia[J]. Nature, 1987, 330(6149): 662-664.
4. Stephenson D A, Toltl L J, Beaudin S, et al. Modulation of monocyte function by activated protein C, a natural anticoagulant [J]. J Immunol, 2006, 177(4): 2115-2122.
5. Kotanidou A, Ioutrari H, Papadomichelakis E. Inhaled activated protein C attenuates lung injury induced by aerosolized endotoxin in mice[J]. Vascul Pharmacol, 2006, 45(2): 134-140.
6. Chaudry I H, Wichterman K A, Baue A E. Effect of sepsis on tissue adenine nucleotide levels [J]. Surgery, 1979, 85 (2): 205-211.
7. Chinese source.
8. Zervos E E, Kramer A A, Salhab K F, et al. Sublethal hemorrhage blunts the inflammatory cytokine response to endotoxin in a rat model[J]. J Trauma, 1999, 46(1): 145-149.
9. Ye X, Fukudome K, Tsuneyoshi N, et al. The endothelial cell protein C receptor (EPCR) functions as a primary receptor for protein C activation on endothelial cells in arteries, veins, and capillaries [J]. Biochem Biophys Res Commun, 1999, 259 (3): 671-677.
10. Chinese source.
11. Brueckmann M, Hoffmann U, Dvortsak E, et al. Drotrecogin alfa (activated) inhibits NF-kappa B activai ion and MIP-1-alpha release from isolated mononuclear cells of patients with severe sepsis[J]. Inflamm Res, 2004, 53(10): 528-533.
12. Yuksel M, Okajima K, Uchiba M, et al. Activated protein C inhibits lipopolysaccharide-induced tumor necrosis factor-alpha production by inhibiting activation of both nuclear factor-kappa B and activator protein-1 in human monocytes [J]. Thromb Haemost, 2002, 88(2): 267-273.
13. Slofstra S H, Groot A P, Maris N A, et al. Inhalation of activated protein C inhibits endotoxin-induced pulmonary inflammation in mice independent of neutrophil recruitment[J]. Br J Pharmacol, 2006, 149(6): 740-746.
14. Kotanidou A, Loutrari H, Papadomichelakis E, et al. Inhaled activated protein C attenuates lung injury induced by aerosolized endotoxin in mice[J]. Vascul Pharmacol, 2006, 45(2): 134-140.
15. Kurosawa S, Stearns-Kurosawa D J, Carson C W, et al. Plasma levels of endothelial cell protein C receptor are elevated in patients with sepsis and systemic lupus erythematosus: lack of correlation with thrombomodulin suggests involvement of different pathological processes [J]. Blood, 1998, 91 (2): 725-727.
16. Regan L M, Stearns-Kurosawa D J, Kurosawa S, et al. The endothelial cell protein C receptor: inhibition of activated protein C anticoagulant function without modulation of reaction with proteinase inhibitors [J]. J Biol Chem, 1996, 271 (29): 17499-17503.
17. Heuer J G, Sharma G R, Gerlitz B, et al. Evaluation of protein C and other biomarkers as predictors of mortality in a rat cecal ligation and puncture model of sepsis[J]. Crit Care Med, 2004, 32 (7): 1570-1578.